Related Experiment Video
Updated: Apr 29, 2026

12:40
Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
9.7K
Human iPSC-derived miniature organs: a tool for drug studies
11] Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan [2] PRESTO, Japan Science and Technology Agency, Kawaguchi, Saitama, Japan.
Clinical Pharmacology and Therapeutics
|May 23, 2014
Summary
Stem cell biology advances organogenesis research. New four-dimensional culture systems aim to mimic in vivo development for creating miniature organs from induced pluripotent stem cells.
Area of Science:
- Stem cell biology
- Developmental biology
- Tissue engineering
Background:
- In vitro organogenesis is a growing field in stem cell biology.
- Reprogramming technology provides an abundant source of pluripotent stem cells.
- Current limitations exist in replicating the complex spatiotemporal communication of in vivo organogenesis.
Purpose of the Study:
- To explore the potential of emerging culture platforms for in vitro organogenesis.
- To discuss the application of induced pluripotent stem cell (iPSC)-derived miniature organs.
- To highlight the recapitulation of early embryogenesis in engineered systems.
Main Methods:
- Review of current stem cell culture technologies.
- Analysis of four-dimensional (4-D) culture system requirements.
- Perspective on recapitulating spatiotemporal progenitor communication.
Main Results:
- Emerging culture platforms show promise for advanced in vitro organogenesis.
- Four-dimensional (4-D) culture systems are crucial for mimicking in vivo development.
- The recapitulation of early embryogenesis is key to generating functional miniature organs.
Conclusions:
- Advancements in stem cell biology and culture platforms are paving the way for in vitro organogenesis.
- Developing sophisticated 4-D culture systems is essential for future success.
- iPSC-derived miniature organs hold significant potential for regenerative medicine and research.

